Electrolytic ablation of the rat pancreas: a feasibility trial

BACKGROUND: Pancreatic cancer is a biologically aggressive disease with less than 20% of patients suitable for a "curative" surgical resection. This, combined with the poor 5-year survival indicates that effective palliative methods for symptom relief are required. Currently there are no a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fosh, Beverley G, Finch, Jonathon Guy, Anthony, Adrian A, Texler, Michael, Maddern, Guy J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56592/
https://www.ncbi.nlm.nih.gov/pubmed/11570977
http://dx.doi.org/10.1186/1471-230X-1-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56592/
https://www.ncbi.nlm.nih.gov/pubmed/11570977
http://dx.doi.org/10.1186/1471-230X-1-9

Ejemplares similares